reata pharmaceuticals stock analysis

Based in Plano Texas Reata is a biopharmaceutical developer of novel therapeutics for patients. RETA Stock Overview.

Reta Stock Price And Chart Nasdaq Reta Tradingview

RETA shares soared 206 in the last trading session to close at 3021.

. Reata Pharma Stock analysis including Reata Pharma investment evaluation stock information alerts predictive tools such as market volatility and liquidity estimators and more. On a sharply down day at the tail end of the week Reata Pharmaceuticals NASDAQ. The Reata Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations Crowd Wisdom Hedge.

Find out more here. Reata Pharmaceuticals Inc. RETA Reata the Company or we a clinical-stage biopharmaceutical company today announced that.

Ad Horizon Is A Leading High-Growth Biopharma Company. 1 day agoReata Pharmaceuticals Inc. VIX options and futures.

Ad Discover a Path to Financial Security. RETA stock analysis from Seeking Alphas top analysts. See Reata Pharmaceuticals Inc.

Discover Which Investments Align with Your Financial Goals. Exclusive research and insights from bulls and bears. RETA stock jumped 15 in the morning session before moving even higher in the afternoon.

PLANO Texas September 06 2022--Reata Pharmaceuticals Inc. Reata Pharmaceuticals Inc. Further Reata Pharmaceuticals Inc.

Ex-dividend Dates and Stock Data Free Trial. RETA stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Ad The Amazing Stock Dividends.

Find Reata Pharmaceuticals Smart Score expert sentiment charts stats. See a free in-depth analysis of DE2R3 stock including forecasts from trusted sources. The move was backed by solid volume with far more shares changing hands.

Guggenheim assumed coverage on shares of Reata Pharmaceuticals NASDAQRETA Get Rating in a report issued on Wednesday Marketbeat reports. RETA Reata the Company or we a clinical-stage biopharmaceutical company today announced that abstracts highlighting clinical. Is a clinical-stage biopharmaceutical company that is focused on identifying developing and commercializing.

Find the average price target expert sentiment charts stats. Wide Range Of Investment Choices Including Options Futures and Forex. Reata Pharmaceuticals Inc a clinical-stage biopharmaceutical company identifies develops and commercializes novel therapeutics for.

Find the latest Reata Pharmaceuticals Inc. RETA Reata the Company or we a clinical-stage biopharmaceutical company today announced that abstracts highlighting clinical. Ex-Dividend Dates Dividend Calendar All-Star Rankings Special Divs More.

Find a Dedicated Financial Advisor Now. Reata Pharmaceuticals Inc a clinical-stage biopharmaceutical company identifies develops and commercializes novel therapeutics for patients with serious or life-threatening diseases. RETA has a beta value of 107 and an average true range ATR of 251.

In the Healthcare Industry of Biotechnology. Reata Pharmaceuticals Inc. Learn More About Our Differentiated RD Strategy.

The company is developing Phase 3 clinical trial programs including bardoxolone methyl bardoxolone for the treatment of patients with. Ad Manage volatility w a tool that directly tracks the vol market. Get a free in-depth analysis of Reata Pharmaceuticals RETA stock.

Reatas development programs have created a robust pipeline of drug candidates for the treatment of serious life-threatening diseases. Analysts have given the companys stock an average 52-week price.

Reata Pharmaceuticals Inc Reta Stock Price Quote News Stock Analysis

Reata Pharmaceuticals Inc Reta Stock 10 Year History

Reta Stock Forecast Price News Reata Pharmaceuticals

Reta Stock Price And Chart Nasdaq Reta Tradingview

Reata Alert Bragar Eagel Squire P C Reminds Investors That A Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals Inc And Encourages Investors To Contact The Firm Lawyer Monthly